This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Sep;30(10):1434-5.

doi: 10.1002/mds.26315. Epub 2015 Jul 17.

Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel

Nika Zorko^{1

2}, Maja Kojovic¹, Dusan Flisar³, Zvezdan Pirtosek¹, Milica Gregoric Kramberger¹

Affiliations

Affiliations

¹ Department of Neurology, University Medical Center, Ljubljana, Slovenia.
² Department of Neurology, General Hospital, Novo mesto, Slovenia.
³ Department of Neurology, University Medical Center, Maribor, Slovenia.

PMID: 26184074
DOI: 10.1002/mds.26315

Comment

Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel

Nika Zorko et al. Mov Disord. 2015 Sep.

. 2015 Sep;30(10):1434-5.

doi: 10.1002/mds.26315. Epub 2015 Jul 17.

Authors

Nika Zorko^{1

2}, Maja Kojovic¹, Dusan Flisar³, Zvezdan Pirtosek¹, Milica Gregoric Kramberger¹

Affiliations

¹ Department of Neurology, University Medical Center, Ljubljana, Slovenia.
² Department of Neurology, General Hospital, Novo mesto, Slovenia.
³ Department of Neurology, University Medical Center, Maribor, Slovenia.

PMID: 26184074
DOI: 10.1002/mds.26315

No abstract available

PubMed Disclaimer

Comment in

Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel.
Fernandez HH, Standaert DG, Chatamra K, Benesh JA. Fernandez HH, et al. Mov Disord. 2015 Sep;30(10):1435-6. doi: 10.1002/mds.26316. Epub 2015 Jul 16. Mov Disord. 2015. PMID: 26179940 Free PMC article. No abstract available.
Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.
Solla P, Fasano A, Cannas A, Marrosu F. Solla P, et al. Mov Disord. 2015 Nov;30(13):1859-60. doi: 10.1002/mds.26443. Epub 2015 Oct 10. Mov Disord. 2015. PMID: 26452673 No abstract available.

Comment on

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ. Fernandez HH, et al. Mov Disord. 2015 Apr;30(4):500-9. doi: 10.1002/mds.26123. Epub 2014 Dec 24. Mov Disord. 2015. PMID: 25545465 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information